Diabetes Research and Clinical Practice
Volume 73, Issue 3 , Pages 276-283 , September 2006

The current status of home and office blood pressure control among hypertensive patients with diabetes mellitus: The Japan Home Versus Office Blood Pressure Measurement Evaluation (J-HOME) study

  • Taku Obara

      Affiliations

    • Departments of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Science and Medicine, Tohoku University Hospital, 1-1 Seiryo-cho, Aoba-ku, Sendai 980-8574, Japan
    • Tohoku University 21st Century COE Program “Comprehensive Research and Education Center for Planning of Drug Development and Clinical Evaluation”, Sendai, Japan
    • ,
  • Takayoshi Ohkubo

      Affiliations

    • Departments of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Science, Sendai, Japan
    • Tohoku University 21st Century COE Program “Comprehensive Research and Education Center for Planning of Drug Development and Clinical Evaluation”, Sendai, Japan
    • ,
  • Masahiro Kikuya

      Affiliations

    • Departments of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Science, Sendai, Japan
    • ,
  • Kei Asayama

      Affiliations

    • Departments of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Science and Medicine, Tohoku University Hospital, 1-1 Seiryo-cho, Aoba-ku, Sendai 980-8574, Japan
    • Tohoku University 21st Century COE Program “Comprehensive Research and Education Center for Planning of Drug Development and Clinical Evaluation”, Sendai, Japan
    • ,
  • Hirohito Metoki

      Affiliations

    • Departments of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Science and Medicine, Tohoku University Hospital, 1-1 Seiryo-cho, Aoba-ku, Sendai 980-8574, Japan
    • Tohoku University 21st Century COE Program “Comprehensive Research and Education Center for Planning of Drug Development and Clinical Evaluation”, Sendai, Japan
    • ,
  • Ryusuke Inoue

      Affiliations

    • Tohoku University 21st Century COE Program “Comprehensive Research and Education Center for Planning of Drug Development and Clinical Evaluation”, Sendai, Japan
    • ,
  • Takuya Oikawa

      Affiliations

    • Departments of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Science and Medicine, Tohoku University Hospital, 1-1 Seiryo-cho, Aoba-ku, Sendai 980-8574, Japan
    • ,
  • Kayo Murai

      Affiliations

    • Departments of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Science and Medicine, Tohoku University Hospital, 1-1 Seiryo-cho, Aoba-ku, Sendai 980-8574, Japan
    • ,
  • Rie Komai

      Affiliations

    • Departments of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Science and Medicine, Tohoku University Hospital, 1-1 Seiryo-cho, Aoba-ku, Sendai 980-8574, Japan
    • ,
  • Tsuyoshi Horikawa

      Affiliations

    • Departments of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Science and Medicine, Tohoku University Hospital, 1-1 Seiryo-cho, Aoba-ku, Sendai 980-8574, Japan
    • ,
  • Junichiro Hashimoto

      Affiliations

    • Departments of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Science, Sendai, Japan
    • Tohoku University 21st Century COE Program “Comprehensive Research and Education Center for Planning of Drug Development and Clinical Evaluation”, Sendai, Japan
    • ,
  • Kazuhito Totsune

      Affiliations

    • Departments of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Science and Medicine, Tohoku University Hospital, 1-1 Seiryo-cho, Aoba-ku, Sendai 980-8574, Japan
    • Tohoku University 21st Century COE Program “Comprehensive Research and Education Center for Planning of Drug Development and Clinical Evaluation”, Sendai, Japan
    • ,
  • Yutaka Imai

      Affiliations

    • Departments of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Science and Medicine, Tohoku University Hospital, 1-1 Seiryo-cho, Aoba-ku, Sendai 980-8574, Japan
    • Tohoku University 21st Century COE Program “Comprehensive Research and Education Center for Planning of Drug Development and Clinical Evaluation”, Sendai, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 22 717 7770; fax: +81 22 717 7776.
    • ,
  • The J-HOME Study Group

Received 20 October 2005 ,Revised 19 December 2005 ,Accepted 31 January 2006.

References 

  1. Curb JD, Pressel SL, Cutler JA, Savage PJ, Applegate WB, Black H, et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic hypertension in the Elderly Program Cooperative Research Group. JAMA. 1996;276:1886–1892
  2. Tuomilehto J, Rastenyte D, Birkenhager WH, Thijs L, Antikainen R, Bulpitt CJ, et al. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic hypertension in Europe trial investigators. N. Engl. J. Med. 1999;340:677–684
  3. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial. HOT Study Group. Lancet. 1998;351:1755–1762
  4. United Kingdom Prospective Diabetes Study (UKPDS) Group . Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703–713
  5. CDC Diabetes Cost-effectiveness Group . Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA. 2002;287:2542–2551
  6. Whitworth JA. World Health Organization, International Society of Hypertension Writing Group: 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J. Hypertens. 2003;21:1983–1992
  7. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, J.L. Izzo, et al., The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report, JAMA 289 (2003) 2560–2572.
  8. Reims H, Fossum E, Kjeldsen SE, Julius S. Home blood pressure monitoring. Current knowledge and directions for future research. Blood Press. 2001;10:271–287
  9. Imai Y, Ohkubo T, Hozawa A, Tsuji I, Matsubara M, Araki T, et al. Usefulness of home blood pressure measurements in assessing the effect of treatment in a single-blind placebo-controlled open trial. J. Hypertens. 2001;19:179–185
  10. Ohkubo T, Asayama K, Kikuya M, Metoki H, Hoshi H, Hashimoto J, et al. How many times should blood pressure be measured at home for better prediction of stroke risk? Ten-year follow-up results from the Ohasama study. J. Hypertens. 2004;22:1099–1104
  11. Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, et al. Cardiovascular prognosis of “masked hypertension” detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA. 2004;291:1342–1349
  12. David MM, Gregory LK, Paul W, Janet KS, Dana D, John H, et al. Hypertension prevalence, awareness, treatment, and control in an adult Type 1 diabetes population and a comparable general population. Diabetes Care. 2005;28:301–306
  13. Katayama S, Inaba M, Morita T, Awata T, Shimamoto K, Kikkawa R. Blood pressure control in Japanese hypertensives with or without type 2 diabetes mellitus. Hypertens. Res. 2000;23:601–605
  14. Ohkubo T, Obara T, Funahashi J, Kikuya M, Asayama K, Metoki H, et al. Control of blood pressure as measured at home and office, and comparison with physicians’ assessment of control among treated hypertensive patients in Japan: first report of the J-HOME study. Hypertens. Res. 2004;27:755–763
  15. Obara T, Ohkubo T, Funahashi J, Kikuya M, Asayama K, Metoki H, et al. Isolated uncontrolled hypertension at home and in the office among treated hypertensive patients from the J-HOME study. J. Hypertens. 2005;23:1653–1660
  16. Imai Y, Otsuka K, Kawano Y, Shimada K, Hayashi H, Tochikubo O, et al. Japanese society of hypertension guidelines for self-monitoring of blood pressure at home. Hypertens. Res. 2003;26:771–782
  17. Shirasaki O, Terada H, Niwano K, Nakanishi T, Kanai M, Miyawaki Y, et al. The Japan Home-Health Apparatus Industrial Association: investigation of home-use electronic sphygmomanometers. Blood Press. Monit. 2001;6:303–307
  18. Association for the Advancement of Medical Instrumentation, American National Standard for Electronic or Automated Sphygnomanometers, AAMI Analysis and Review, Washington, DC, 1987.
  19. Kamoi K, Miyakoshi M, Soda S, Kaneko S, Nakagawa O. Usefulness of home blood pressure measurement in the morning in type 2 diabetic patients. Diabetes Care. 2002;25:2218–2223
  20. Mazze RS, Simonson GD, Robinson RL, Kendall DM, Idrogo MA, Adlis SA, et al. Characterizing blood pressure control in individuals with Type 2 diabetes: the relationship between clinic and self-monitored blood pressure. Diabet. Med. 2003;20:752–757
  21. Oliveria SA, Lapuerta P, McCarthy BD, L’Italien GJ, Berlowitz DR, Asch SM. Physician-related barriers to the effective management of uncontrolled hypertension. Arch. Intern. Med. 2002;162:413–420
  22. American Diabetes Association . Treatment of hypertension in adults with diabetes. Diabetes Care. 2002;25(Suppl. 1):S71–S75
  23. Hirose H, Saito I. Trends in blood pressure control in hypertensive patients with diabetes mellitus in Japan. Hypertens. Res. 2003;26:717–722
  24. Turnbull F, Neal B, Algert C, Chalmers J, Chapman N, Cutler J, et al. Blood Pressure Lowering Treatment Trialists’ Collaboration: effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus—results of prospectively designed overviews of randomized trials. Arch. Intern. Med. 2005;165:1410–1419
  25. Whelton PK, Barzilay J, Cushman WC, Davis BR, Iiamathi E, Kostis JB, et al. ALLHAT Collaborative Research Group Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). Arch. Intern. Med. 2005;165:1401–1409
  26. Berlowitz DR, Ash AS, Hickey EC, Glickman M, Friedman R, Kader B. Hypertension management in patients with diabetes: the need for more aggressive therapy. Diabetes Care. 2003;26:355–359
  27. Hyman DJ, Pavlik VN. Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Arch. Intern. Med. 2000;160:2281–2286
  28. Miller NH, Hill M, Kottke T, Ockene IS. The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals. Circulation. 1997;95:1085–1090
  29. Ekpo EB, Shah IU, Fernando MU, White AD. Isolated systolic hypertension in the elderly: survey of practitioners’ attitude and management. Gerontology. 1993;39:207–214
  30. Pellegrini F, Belfiglio M, De Berardis G, Franciosi M, Di Nardo B, Greenfield S, et al. Role of organizational factors in poor blood pressure control in patients with type 2 diabetes: the QuED Study Group—quality of care and outcomes in type 2 diabetes. Arch. Intern. Med. 2003;163:473–480

PII: S0168-8227(06)00057-X

doi: 10.1016/j.diabres.2006.01.015

Diabetes Research and Clinical Practice
Volume 73, Issue 3 , Pages 276-283 , September 2006

Article Tools

* Image Usage & Resolution